FLT3 and acute myeloid leukemia: Besides direct action on AML cells, indirect effects of FLT3 inhibitors, such as weakened expression of PD-1 and TIGIT within donor CD8+ T cells and increased production of IL-15, enhance the graft-versus-leukemia effect.